- Price
- $30.00
- Day
- +9.33%
- Mkt Cap
- $78.84M
- 52W Range
- $4.98 – $45.50
- Volume
- 258.9K
- Beta
- 2.46
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
NEW YORK, Aug. 24, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Cue Biopharma, Inc. (NASDAQ: CUE) on behalf of the company's shareholders. The investigation seeks to determine whether Cue Biopharma's directors breached their fiduciary duties in connection with recent corporate actions.
Read full article